Clinical evaluation of neoadjuvant tyrosine kinase inhibitor administration for mast cell tumours in eight dogs

Complete surgical removal of tumour cells is the first‐line treatment for canine cutaneous mast cell tumours. Surgical removal of mast cell tumours sometimes requires radical surgery. This may cause severe complications, loss of biological function or poor cosmetic outcomes. This report describes th...

Full description

Saved in:
Bibliographic Details
Published in:Veterinary record case reports 2023-09, Vol.11 (3), p.n/a
Main Authors: Kanai, Eiichi, Sato, Asaka, Yamauchi, Akinori, Yoshida, Hiromitsu, Takagi, Satoshi
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Complete surgical removal of tumour cells is the first‐line treatment for canine cutaneous mast cell tumours. Surgical removal of mast cell tumours sometimes requires radical surgery. This may cause severe complications, loss of biological function or poor cosmetic outcomes. This report describes the clinical outcomes of preoperative administration of an effective tyrosine kinase inhibitor for mast cell tumours. Five of eight cases responded to tyrosine kinase inhibitors; complete removal was possible in three cases with narrower (
ISSN:2052-6121
2052-6121
DOI:10.1002/vrc2.651